Grace Wright is a Rheumatology/Immunology physician affiliated with Grace. OpenAlex indexes 44 publications with 536 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
345 E 37th St
Suite 303c
New York, NY 100163256
Telephone
212-490-6960Registry record last updated 8 Jul 2007.
Industry payments
36 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year2025136 payments$145,672openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202560 payments$121,047openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year202529 payments$50,730openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
57.8%RANK Ligand Inhibitor56.4%Denosumab100%Part B, office-administered≥51 patientsAlkaloid0.7%Colchicine100%Part D≥21 patients+ 2 more classes in this area
Dermatology
33.5%Corticosteroid33.2%Methylprednisolone acetate100%Part B, office-administered≥25 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.2%Acyclovir100%Part D<11 patientsMetabolism & gastrointestinal
2.5%Corticosteroid1.6%Prednisone100%Part D≥36 patientsAntidiarrheal microorganisms0.3%Folic Acid100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Advances and barriers in gender equity within Brazilian rheumatology: a two-year follow-up study
Revista Brasileira de Reumatologia
2026 - Health Disparities in Rheumatology in the United States
Open Access Rheumatology Research and Reviews
2025 - Seven principles for integrating health equity considerations in the practice guideline enterprise
Journal of Clinical Epidemiology
2025 - The Influence of Race, Ethnicity and Historical Redlining on Psoriatic Disease Burden and Clinical Outcomes
Arthritis & Rheumatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”